Analyst Price Targets — TMDX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 9, 2026 11:13 am | — | Stifel Nicolaus | $130.00 | $134.77 | TheFly | TransMedics price target raised to $130 from $115 at Stifel |
| December 17, 2025 12:23 pm | — | Canaccord Genuity | $148.00 | $125.04 | TheFly | TransMedics price target raised to $148 from $147 at Canaccord |
| December 8, 2025 12:35 pm | — | Needham | $166.00 | $136.51 | TheFly | TransMedics price target raised to $166 from $148 at Needham |
| December 2, 2025 11:39 am | — | Morgan Stanley | $135.00 | $150.42 | TheFly | TransMedics price target raised to $135 from $123 at Morgan Stanley |
| October 30, 2025 11:14 am | Matt O'Brien | Piper Sandler | $140.00 | $134.32 | TheFly | TransMedics price target lowered to $140 from $145 at Piper Sandler |
| October 30, 2025 10:27 am | Jason Mills | Canaccord Genuity | $147.00 | $134.32 | StreetInsider | TransMedics Group (TMDX) PT Raised to $147 at Canaccord Genuity |
| October 23, 2025 9:53 am | — | Needham | $148.00 | $119.54 | TheFly | TransMedics upgraded to Buy from Hold at Needham |
| October 13, 2025 9:20 am | — | Jefferies | $145.00 | $107.29 | TheFly | TransMedics initiated with a Buy at Jefferies |
| October 7, 2025 10:42 am | — | Evercore ISI | $155.00 | $113.93 | TheFly | TransMedics added to 'Tactical Underperform' list at Evercore ISI |
| December 11, 2024 11:58 am | David Rescott | Robert W. Baird | $120.00 | $67.36 | TheFly | TransMedics price target lowered to $120 from $150 at Baird |
Latest News for TMDX
TransMedics Group's innovative approach could help it capture a larger share of the organ transplant market. Dexcom still has vast untapped opportunities in its niche.
On April 10, 2026, TransMedics Group Inc (TMDX) shares rose 4.4% today, bringing the current price to $114.00. The stock has exhibited a 52-week range of $72.78
SG Americas Securities LLC grew its position in TransMedics Group, Inc. (NASDAQ: TMDX) by 125.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,725 shares of the company's stock after buying an additional 8,762 shares during the quarter. SG Americas Securities
TransMedics Group (NASDAQ: TMDX - Get Free Report) and WORK Medical Technology Group (NASDAQ: WOK - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations and earnings. Earnings and Valuation This table compares
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for TMDX.
U.S. House Trading
No House trades found for TMDX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.